Poland· PL-100199582
Metajodobenzyloguanidyna 131 I (MIBG- 131 I) do diagnostyki
A iobenguane (131i) product containing iobenguani (131i) solutio iniectabilis ad usum diagnosticum, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Iobenguane (131i) is registered in 2 of 19 countries.
Countries holding a registration under ATC V09IX02 (iobenguane (131i)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Iobenguane (131i) · ATC V09IX02
2 / 19 countries
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Iobenguani (131I) solutio iniectabilis ad usum diagnosticum
- Manufacturer
- Narodowe Centrum Badań Jądrowych
- Country
- Poland (PL)
- ATC code
- V09IX02
- ATC class
- Iobenguane (131I)
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990665242
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
241 interactions on record for iobenguane (131i).
Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iobenguane (131i) · interactions on record
241 records
- 143 severe
- 98 moderate
Most severe, free to view
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- MazindolA08AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V09IX02
Iobenguane (131i), as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/353c5436-e347-4f79-8e71-5cfa41000d84 GET /v1/drugs/353c5436-e347-4f79-8e71-5cfa41000d84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "10-37 MBq/ml",
"packaging": "05909990665242 ¦ Lz ¦ 45980\n1 fiol.",
"substance": "Meta-jodo[131I]benzyloguanidyny siarczan 10-37 MBq/ml",
"common_name": "Iobenguani (131I) solutio iniectabilis ad usum diagnosticum",
"pl_product_id": "100199582",
"pozwolenie_nr": "19000",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about iobenguane (131i).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.